Managing comorbidities in COPD
Open accessThe DOI matches its Crossref record; 185 of the 185 references it cites were found in a registry or an index.
Abstract
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. Age and smoking are common risk factors for COPD and other illnesses, often leading COPD patients to demonstrate multiple coexisting comorbidities. COPD exacerbations and comorbidities contribute to the overall severity in individual patients. Clinical trials investigating the treatment of COPD routinely exclude patients with multiple comorbidities or advanced age. Clinical practice guidelines for a specific disease do not usually address comorbidities in their recommendations. However, the management and the medical intervention in COPD patients with comorbidities need a holistic approach that is not clearly established worldwide. This holistic approach should include the specific burden of each comorbidity in the COPD severity classification scale. Further, the pharmacological and nonpharmacological management should also include optimal interventions and risk factor modifications simultaneously for all diseases. All health care specialists in COPD management need to work together with professionals specialized in the management of the other major chronic diseases in order to provide a multidisciplinary approach to COPD patients with multiple diseases. In this review, we focus on the major comorbidities that affect COPD patients. We present an overview of the problems faced, the reasons and risk factors for the most commonly encountered comorbidities, and the burden on health care costs. We also provide a rationale for approaching the therapeutic options of the COPD patient afflicted by comorbidity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742 · cited 1×
“The COMCOLD (COMorbidities in Chronic Obstructive Lung Disease) index addresses the combined effect of COPD comorbidities on mortality and health-related quality of life.(152) The use in clinical practice of multiple comorbidity indexes is a powerful tool for better stratifying COPD patients according to their risk fo…”
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879
PAUWELS, R. A., BUIST, A. S., CALVERLEY, P. M. A., JENKINS, C. R., & HURD, S. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.2101039 · Cited by 6,587
Global Initiative for Chronic Obstructive Lung Disease
Gerald, L. B., & Bailey, W. C. (2002) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200207000-00004 · Cited by 5,830
Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-456so · Cited by 4,925 · cited 1×
“mortality worldwide, especially among smokers over 40 years of age and individuals exposed to biomass smoke.(1) The World Health Organization estimates that COPD will”
DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2101 · Cited by 4,177 · cited 1×
“97 Depression reduces physical activity, quality of life scores, 98,99 and adherence to medical treatment, 100 and is associated with higher rates of COPD exacerbations 101,102 and increased mortality.”
ESC/EAS Guidelines for the management of dyslipidaemias
Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr158 · Cited by 3,549
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Yates, J. C., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,248 · cited 1×
“Inhaled anticholinergics can affect intraocular pressure and bladder function and might have cardiovascular effects.(130,131) Inhaled corticosteroids may”
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
Hurst, J. R., Vestbo, J., Anzueto, A., Locantore, N., Müllerova, H., Tal-Singer, R., Miller, B., Lomas, D. A., Agusti, A., MacNee, W., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909883 · Cited by 2,981 · cited 2×
“Studies show a significant prevalence of GERD in up to 60% of COPD patients, which is correlated more with quality of life scores on the COPD Assessment Test than with airway obstruction(113) and risk for exacerbation.(19,114) These findings raise more questions as to whether COPD patients are dealing with an independ…”
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
The Emerging Risk Factors Collaboration (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008862 · Cited by 2,726
Systemic manifestations and comorbidities of COPD
Barnes, P. J., & Celli, B. R. (2009) · European Respiratory Journal · doi:10.1183/09031936.00128008 · Cited by 1,820 · cited 1×
“Without overlooking other pathways, like hypoxia and oxidative stress, the mainstream approach is that a variety of inflammatory mediators, including interferon-γ, interleukin-1, C-reactive protein, tumor necrosis factor-α, interleukin-6, interleukin-8, surfactant protein D, fibrinogen, and amyloid protein, from the p…”
Defining Comorbidity: Implications for Understanding Health and Health Services
Valderas, J. M., Starfield, B., Sibbald, B., Salisbury, C., & Roland, M. (2009) · The Annals of Family Medicine · doi:10.1370/afm.983 · Cited by 1,722
A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
Tashkin, D. P., Celli, B., Senn, S., Burkhart, D., Kesten, S., Menjoge, S., & Decramer, M. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805800 · Cited by 1,604 · cited 1×
“In UPLIFT, a 4-year trial of tiotropium in COPD, 5,993 patients were enrolled.(17) At visit 2 of the study, prebronchodilator”
Rodríguez, R. (2007) · Cited by 1,391
Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease
Divo, M., Cote, C., de Torres, J. P., Casanova, C., Marin, J. M., Pinto-Plata, V., Zulueta, J., Cabrera, C., Zagaceta, J., Hunninghake, G., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201201-0034oc · Cited by 1,275 · cited 5×
“These include the Charlson Comorbidity Index, the Cumulative Illness Rating Scale, the Index of Coexisting Disease, and the Kaplan Index.(10,151) The COTE index (a COPD-specific comorbidity test) identified 12 comorbidities that predicted death in COPD patients and is suggested as a complementary tool to the BODE (BMI…”
InfluentialEpidemiology of atrial fibrillation: European perspective
Zoni-Berisso, M., Lercari, F., Carazza, T., & Domenicucci, S. (2014) · Clinical Epidemiology · doi:10.2147/clep.s47385 · Cited by 1,273 · cited 1×
“with arrhythmia has been reported to be as high as 31%, compared with 8% in non-COPD patients.(46) Prolonged”
The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality: A Randomized Clinical Trial
Anthonisen, N. R., Skeans, M. A., Wise, R. A., Manfreda, J., Kanner, R. E., Connett, J. E., & for the Lung Health Study Research Group* (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-4-200502150-00005 · Cited by 1,237
Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD
Mannino, D. M., Thorn, D., Swensen, A., & Holguin, F. (2008) · European Respiratory Journal · doi:10.1183/09031936.00012408 · Cited by 1,184 · cited 1×
“COPD patients have a relatively increased risk of developing diabetes, 66,67 but also diabetes often presents before diagnosis of COPD, and diabetic patients have an increased risk of developing COPD.”
Sin, D. D., & Man, S. F. P. (2003) · Circulation · doi:10.1161/01.cir.0000056767.69054.b3 · Cited by 1,082
Mortality in COPD: role of comorbidities
Sin, D. D., Anthonisen, N. R., Soriano, J. B., & Agusti, A. G. (2006) · European Respiratory Journal · doi:10.1183/09031936.00133805 · Cited by 1,052
Gottlieb, S. S., McCarter, R. J., & Vogel, R. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390801 · Cited by 982 · cited 1×
“The use of angiotensin-converting enzyme (ACE) inhibitors by smokers may protect against a rapid decline in lung function and progression to COPD.(164) Chronic lowering of ACE improves pulmonary inflammation, respiratory muscle function, and peripheral use of oxygen.”
Chronic obstructive pulmonary disease
Decramer, M., Janssens, W., & Miravitlles, M. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60968-9 · Cited by 972
Wedzicha, J. A., Calverley, P. M. A., Seemungal, T. A., Hagan, G., Ansari, Z., & Stockley, R. A. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200707-973oc · Cited by 827
Risk factors of readmission to hospital for a COPD exacerbation: a prospective study
Garcia-Aymerich, J. (2003) · Thorax · doi:10.1136/thorax.58.2.100 · Cited by 731 · cited 1×
“Pulmonary fibrosis is more common among smokers, and in coexistence with emphysema it has been classified as a distinct clinical entity (combined pulmonary fibrosis and emphysema syndrome).(28) Patients with coexistence of pulmonary interstitial fibrosis and COPD present characteristic lung function tests, with relati…”
Exercise for type 2 diabetes mellitus
Thomas, D., Elliott, E. J., & Naughton, G. A. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002968.pub2 · Cited by 728 · cited 2×
“Similarly, the percentage of the population that currently receives influenza vaccination is also low.(172) The harmful and beneficial effects of pharmacological”
Severe Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
Chaouat, A., Bugnet, A.-S., Kadaoui, N., Schott, R., Enache, I., Ducoloné, A., Ehrhart, M., Kessler, R., & Weitzenblum, E. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200401-006oc · Cited by 714 · cited 1×
“The coexistence of COPD and pulmonary artery hypertension is associated with higher mortality.(50) Signs and symptoms of”
Marin, J. M., Soriano, J. B., Carrizo, S. J., Boldova, A., & Celli, B. R. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200912-1869oc · Cited by 699 · cited 1×
“The combination leads to increased risk of death(107,108) due to more frequent exacerbations and an increased risk for development of cardiovascular comorbidities like pulmonary hypertension and right heart failure.(24,109)”
COPD prevalence is increased in lung cancer, independent of age, sex and smoking history
Young, R. P., Hopkins, R. J., Christmas, T., Black, P. N., Metcalf, P., & Gamble, G. D. (2009) · European Respiratory Journal · doi:10.1183/09031936.00144208 · Cited by 695 · cited 9×
“Smoking cessation is the most cost-effective method for slowing COPD progression, and has proven beneficial effects on the outcomes of most comorbidities, for which smoking is a major risk factor.(24) Despite the abundance of data on smoking, only a small percentage of smokers in the USA have received any kind of smok…”
InfluentialComplex chronic comorbidities of COPD
Fabbri, L. M., Luppi, F., Beghé, B., & Rabe, K. F. (2008) · European Respiratory Journal · doi:10.1183/09031936.00114307 · Cited by 660 · cited 1×
“68 71 Diabetes worsens the outcomes of COPD by affecting a number of parameters: 66,72,73 shortening time to first hospitalization and increasing hospitalization time and risk of death during exacerbations, 74 increasing Medical Research Council dyspnea scores, and reducing six-minute walking…”
Surprisingly High Prevalence of Anxiety and Depression in Chronic Breathing Disorders
Kunik, M. E., Roundy, K., Veazey, C., Souchek, J., Richardson, P., Wray, N. P., & Stanley, M. A. (2005) · Chest · doi:10.1016/s0012-3692(15)34468-8 · Cited by 650
From COPD to chronic systemic inflammatory syndrome?
Fabbri, L. M., & Rabe, K. F. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61383-x · Cited by 635
Pulmonary hypertension in COPD
Chaouat, A., Naeije, R., & Weitzenblum, E. (2008) · European Respiratory Journal · doi:10.1183/09031936.00015608 · Cited by 625 · cited 1×
“Reports estimate that the prevalence of pulmonary artery hypertension in COPD patients is as high as 40%.(49) When COPD patients develop pulmonary artery hypertension, they experience more intense shortness of breath, greater desaturation during exercise, and more profound limitation of physical activity.”
Ng, T.-P. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.1.60 · Cited by 624 · cited 1×
“103 Almost 25% of all COPD patients suffer from depression that eludes diagnosis, 104 and an estimated two thirds of patients with coexistent COPD and depression do not receive any antidepressant treatment.”
Patterns of Comorbidities in Newly Diagnosed COPD and Asthma in Primary Care
Soriano, J. B., Visick, G. T., Muellerova, H., Payvandi, N., & Hansell, A. L. (2005) · Chest · doi:10.1378/chest.128.4.2099 · Cited by 615 · cited 1×
“Coexistence of asthma and COPD in elderly patients is often diagnosed.(12) In some studies, the overlap diagnosis of asthma and COPD exceeds half of the patients examined.”
Lung Volumes and Emphysema in Smokers with Interstitial Lung Abnormalities
Washko, G. R., Hunninghake, G. M., Fernandez, I. E., Nishino, M., Okajima, Y., Yamashiro, T., Ross, J. C., Estépar, R. S. J., Lynch, D. A., Brehm, J. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007285 · Cited by 611
The overlap syndrome of asthma and COPD: what are its features and how important is it?
Gibson, P. G., & Simpson, J. L. (2009) · Thorax · doi:10.1136/thx.2008.108027 · Cited by 611 · cited 1×
“of airflow in patients with incompletely reversible airway obstruction.(15) The presence of COPD-asthma overlap syn-”
Chronic Obstructive Pulmonary Disease as a Risk Factor for Cardiovascular Morbidity and Mortality
Sin, D. D., & Man, S. F. P. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200404-032ms · Cited by 572 · cited 1×
“In some studies of the medical records of COPD patients, undiagnosed cases of coronary heart disease reach 70%.(40) Addressing undiagnosed cases is crucial for improving outcomes, since the coexistence of both diseases worsens the prognosis when compared with each separately.”
McGarvey, L. P., John, M., Anderson, J. A., Zvarich, M., & Wise, R. A. (2007) · Thorax · doi:10.1136/thx.2006.072348 · Cited by 561
Sidney, S., Sorel, M., Quesenberry, C. P., DeLuise, C., Lanes, S., & Eisner, M. D. (2005) · Chest · doi:10.1378/chest.128.4.2068 · Cited by 540 · cited 1×
“35 Simultaneously, COPD is an independent risk factor for death in patients with congestive heart failure.”
Inhaled corticosteroids for stable chronic obstructive pulmonary disease
Yang, I. A., Clarke, M. S., Sim, E. H., & Fong, K. M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002991.pub3 · Cited by 523
Cavaillès, A., Brinchault-Rabin, G., Dixmier, A., Goupil, F., Gut-Gobert, C., Marchand-Adam, S., Meurice, J.-C., Morel, H., Person-Tacnet, C., Leroyer, C., et al. (2013) · European Respiratory Review · doi:10.1183/09059180.00008612 · Cited by 510
A review of the clinical evidence for exercise in osteoarthritis of the hip and knee
Bennell, K. L., & Hinman, R. S. (2011) · Journal of Science and Medicine in Sport · doi:10.1016/j.jsams.2010.08.002 · Cited by 492
Comorbidities in Chronic Obstructive Pulmonary Disease
Chatila, W. M., Thomashow, B. M., Minai, O. A., Criner, G. J., & Make, B. J. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200709-148et · Cited by 478
Inflammation, Atherosclerosis, and Coronary Artery Disease
(2005) · New England Journal of Medicine · doi:10.1056/nejm200507283530425 · Cited by 476
Janssens, W., Bouillon, R., Claes, B., Carremans, C., Lehouck, A., Buysschaert, I., Coolen, J., Mathieu, C., Decramer, M., & Lambrechts, D. (2010) · Thorax · doi:10.1136/thx.2009.120659 · Cited by 463 · cited 1×
“Even asymptomatic vertebral fractures accelerate lung function decline.(79) Osteoporosis is associated with higher dyspnea scores and reduced six-minute walking distance.”
Weitzenblum, E., Sautegeau, A., Ehrhart, M., Mammosser, M., & Pelletier, A. (1985) · American Review of Respiratory Disease · doi:10.1164/arrd.1985.131.4.493 · Cited by 461 · cited 1×
“venous thromboembolism The prevalence of venous thromboembolism in COPD patients during an exacerbation has been reported to be as high as 29%.(52,53) The prevalence of pulmonary embolism in COPD patients is also documented to be higher than in nonCOPD patients and increases with age.”
Feary, J. R., Rodrigues, L. C., Smith, C. J., Hubbard, R. B., & Gibson, J. E. (2010) · Thorax · doi:10.1136/thx.2009.128082 · Cited by 445
Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort
Miller, J., Edwards, L. D., Agustí, A., Bakke, P., Calverley, P. M. A., Celli, B., Coxson, H. O., Crim, C., Lomas, D. A., Miller, B. E., et al. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2013.05.001 · Cited by 437
The clinical features of the overlap between COPD and asthma
the COPDGene Investigators, Hardin, M., Silverman, E. K., Barr, R. G., Hansel, N. N., Schroeder, J. D., Make, B. J., Crapo, J. D., & Hersh, C. P. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-127 · Cited by 428
Baker, E. H. (2006) · Thorax · doi:10.1136/thx.2005.051029 · Cited by 418 · cited 1×
“…Diabetes worsens the outcomes of COPD by affecting a number of parameters: 66,72,73 shortening time to first hospitalization and increasing hospitalization time and risk of death during exacerbations, 74 increasing Medical Research Council dyspnea scores, and reducing six-minute walking distance.”
The prevalence of quadriceps weakness in COPD and the relationship with disease severity
Seymour, J. M., Spruit, M. A., Hopkinson, N. S., Natanek, S. A., Man, W. D.-C., Jackson, A., Gosker, H. R., Schols, A. M. W. J., Moxham, J., Polkey, M. I., et al. (2010) · European Respiratory Journal · doi:10.1183/09031936.00104909 · Cited by 411 · cited 1×
“and smoking, but is also affected by systemic manifestations of COPD, like systemic inflammation, oxidative stress, and physical inactivity.(84) Skeletal muscle weakness is associated with reduced strength, endurance and exercise capacity, lack of physical activity, impaired quality of life, increased risk for hospita…”
Ehrlich, S. F., Quesenberry, C. P., Van Den Eeden, S. K., Shan, J., & Ferrara, A. (2010) · Diabetes Care · doi:10.2337/dc09-0880 · Cited by 355
Antonelli Incalzi, R., Corsonello, A., Pedone, C., Battaglia, S., Paglino, G., & Bellia, V. (2010) · Chest · doi:10.1378/chest.09-1710 · Cited by 337
Endothelial dysfunction in pulmonary arteries of patients with mild COPD
Peinado, V. I., Barberà, J. A., Ramírez, J., Gómez, F. P., Roca, J., Jover, L., Gimferrer, J. M., & Rodriguez-Roisin, R. (1998) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1998.274.6.l908 · Cited by 334 · cited 1×
“COPD not only shares certain common risk factors with venous thromboembolism, like smoking, but also systemic inflammation due to COPD induces pulmonary 55 and systemic endothelial dysfunction 56 and coagulopathy.”
Casaburi, R. H., Gosselink, R., Decramer, M., Dekhuijzen, R. P. N., Fournier, M., Lewis, M. I., Maltais, F., Oelberg, D., Reid, M. B., Roca, J., et al. (1999) · American Journal of Respiratory and Critical Care Medicine · Cited by 333
Bronchodilator responsiveness in patients with COPD
Tashkin, D. P., Celli, B., Decramer, M., Liu, D., Burkhart, D., Cassino, C., & Kesten, S. (2008) · European Respiratory Journal · doi:10.1183/09031936.00129607 · Cited by 330 · cited 1×
“9% met the criterion of an increase in FEV 1 of both $12% and $200 mL.(18) In ECLIPSE, a large observational study (2,138 COPD patients), researchers tested the hypothesis that there is a frequent-exacerbation phenotype of COPD that is independent of disease severity.”
Le Jemtel, T. H., Padeletti, M., & Jelic, S. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.046 · Cited by 324 · cited 1×
“33,34 Congestive heart failure is among the leading causes of hospitalization and death for patients with COPD and worsens their prognosis.”
Tillie-Leblond, I., Marquette, C.-H., Perez, T., Scherpereel, A., Zanetti, C., Tonnel, A.-B., & Remy-Jardin, M. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-6-200603210-00005 · Cited by 312 · cited 2×
“venous thromboembolism The prevalence of venous thromboembolism in COPD patients during an exacerbation has been reported to be as high as 29%.(52,53) The prevalence of pulmonary embolism in COPD patients is also documented to be higher than in nonCOPD patients and increases with age.”
Xu, W., Collet, J.-P., Shapiro, S., Lin, Y., Yang, T., Platt, R. W., Wang, C., & Bourbeau, J. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200804-619oc · Cited by 311 · cited 1×
“97 Depression reduces physical activity, quality of life scores, 98,99 and adherence to medical treatment, 100 and is associated with higher rates of COPD exacerbations 101,102 and increased mortality.”
Heart Failure and cHronic Obstructive Pulmonary Disease: An Ignored Combination?
Rutten, F. H., Cramer, M.-J. M., Lammers, J.-W. J., Grobbee, D. E., & Hoes, A. W. (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.01.010 · Cited by 291 · cited 1×
“8% to 16% coexistence compared with exacerbations that reach up to 48%.(33,34) Congestive heart failure is among the leading causes of hospitalization and death for patients with COPD and worsens their prognosis.”
Current status of research on osteoporosis in COPD: a systematic review
Graat-Verboom, L., Wouters, E. F. M., Smeenk, F. W. J. M., van den Borne, B. E. E. M., Lunde, R., & Spruit, M. A. (2009) · European Respiratory Journal · doi:10.1183/09031936.50130408 · Cited by 290 · cited 1×
“At the same time, vertebral fractures due to osteoporosis lead to decreased rib mobility and frequently to kyphosis, which further impairs lung mechanics.(78) Even asymptomatic vertebral fractures accelerate lung function decline.”
Pharmacoeconomic Evaluation of COPD
Hilleman, D. E., Dewan, N., Malesker, M., & Friedman, M. (2000) · Chest · doi:10.1378/chest.118.5.1278 · Cited by 288
Impact of comorbidity on lung cancer survival
Tammemagi, C. M., Neslund‐Dudas, C., Simoff, M., & Kvale, P. (2003) · International Journal of Cancer · doi:10.1002/ijc.10882 · Cited by 282 · cited 1×
“The prevalence of COPD among patients with lung cancer varies from 40% to 70%.(22,23) Lung”
Agusti, À., & Soriano, J. B. (2008) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550801941349 · Cited by 276
Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation
Crisafulli, E., Costi, S., Luppi, F., Cirelli, G., Cilione, C., Coletti, O., Fabbri, L. M., & Clini, E. M. (2008) · Thorax · doi:10.1136/thx.2007.086371 · Cited by 272 · cited 1×
“7% among COPD patients.(64,65) The prevalence of metabolic syndrome is reported to be up to 22.”
Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity
Finkelstein, J., Cha, E., & Scharf, S. (2009) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s6400 · Cited by 267
Prevalence and Progression of Osteoporosis in Patients With COPD
Ferguson, G. T., Calverley, P. M. A., Anderson, J. A., Jenkins, C. R., Jones, P. W., Willits, L. R., Yates, J. C., Vestbo, J., & Celli, B. (2009) · Chest · doi:10.1378/chest.08-3016 · Cited by 265 · cited 1×
“77 At the same time, vertebral fractures due to osteoporosis lead to decreased rib mobility and frequently to kyphosis, which further impairs lung mechanics.”
The natural history of chronic obstructive pulmonary disease
Mannino, D. M., Watt, G., Hole, D., Gillis, C., Hart, C., McConnachie, A., Davey Smith, G., Upton, M., Hawthorne, V., Sin, D. D., et al. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00024605 · Cited by 265 · cited 1×
“COPD patients with comorbidities have increased risk(66) and significantly higher mean costs for hospital admissions.(141) Hospitalizations are the greatest contributor to total COPD costs, and account for up to 87% of total COPDrelated costs.”
Mapel, D. W., Hurley, J. S., Frost, F. J., Petersen, H. V., Picchi, M. A., & Coultas, D. B. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.17.2653 · Cited by 252 · cited 3×
“7 times higher compared with comorbidity-free COPD patients.(139) At the same time, compared with non-COPD controls, COPD patients consume 3.”
InfluentialEickhoff, P., Valipour, A., Kiss, D., Schreder, M., Cekici, L., Geyer, K., Kohansal, R., & Burghuber, O. C. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200709-1412oc · Cited by 249 · cited 1×
“Type 2 diabetes has been considered as a coincidental comorbidity, but evidence is accumulating in favor of considering diabetes and metabolic syndrome as dependent comorbidities.(125) Systemic inflammation is the key for linking COPD and most of its dependent comorbidities.”
McNicholas, W. T. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0347pp · Cited by 248 · cited 1×
“Studies show a significant prevalence of GERD in up to 60% of COPD patients, 110–112 which is correlated more with quality of life scores on the COPD Assessment Test than with airway obstruction 113 and risk for exacerbation.”
Proportional classifications of COPD phenotypes
Marsh, S. E., Travers, J., Weatherall, M., Williams, M. V., Aldington, S., Shirtcliffe, P. M., Hansell, A. L., Nowitz, M. R., McNaughton, A. A., Soriano, J. B., et al. (2008) · Thorax · doi:10.1136/thx.2007.089193 · Cited by 244 · cited 1×
“In some studies, the overlap diagnosis of asthma and COPD exceeds half of the patients examined.(13,14)”
Barr, R. G., Mesia-Vela, S., Austin, J. H. M., Basner, R. C., Keller, B. M., Reeves, A. P., Shimbo, D., & Stevenson, L. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200707-980oc · Cited by 237 · cited 1×
“ing, but also systemic inflammation due to COPD induces pulmonary(55) and systemic endothelial dysfunction(56) and coagulopathy.(24,57,58)”
Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis
Barr, R. G. (2006) · Thorax · doi:10.1136/thx.2006.063271 · Cited by 236
Engelen, M. P., Schols, A. M., Does, J. D., & Wouters, E. F. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.3.733 · Cited by 230
Comorbidities, Patient Knowledge, and Disease Management in a National Sample of Patients with COPD
Barr, R. G., Celli, B. R., Mannino, D. M., Petty, T., Rennard, S. I., Sciurba, F. C., Stoller, J. K., Thomashow, B. M., & Turino, G. M. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.09.042 · Cited by 228
Prevalence of Comorbidities in Patients with Chronic Obstructive Pulmonary Disease
Cazzola, M., Bettoncelli, G., Sessa, E., Cricelli, C., & Biscione, G. (2010) · Respiration · doi:10.1159/000281880 · Cited by 228 · cited 1×
“Diabetes worsens 5-year mortality in COPD patients.(24,66)”
COPD and the Risk of Depression
Schneider, C., Jick, S. S., Bothner, U., & Meier, C. R. (2010) · Chest · doi:10.1378/chest.09-0614 · Cited by 213 · cited 1×
“97 Depression reduces physical activity, quality of life scores, 98,99 and adherence to medical treatment, 100 and is associated with higher rates of COPD exacerbations 101,102 and increased mortality.”
Paz-Díaz, H., Montes de Oca, M., López, J. M., & Celli, B. R. (2007) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0b013e31802b8eca · Cited by 209 · cited 2×
“The prevalence of depression in COPD patients receiving long-term oxygen therapy reaches as high as 60%.(97) Depression reduces physical activity, quality of life scores,(98,99) and adherence to medical treatment,(100) and is associated with higher rates of COPD exacerbations(101,102) and increased mortality.”
Cardiovascular events in patients with COPD: TORCH Study results
Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Crim, C., Willits, L. R., Yates, J. C., Vestbo, J., et al. (2010) · Thorax · doi:10.1136/thx.2010.136077 · Cited by 207 · cited 1×
“Bronchodilators are suspected of causing tachyarrhythmias and tremors, but recent randomized clinical trials of long-acting β-agonists suggest that these effects probably do not increase cardiovascular mortality.(128,129) Inhaled anticholinergics can affect intraocular pressure and bladder function and might have card…”
van Manen, J. G., Bindels, P. J. E., IJzermans, C. J., van der Zee, J. S., Bottema, B. J. A. M., & Schadé, E. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00346-8 · Cited by 202
CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD
Machado, M.-C. L., Vollmer, W. M., Togeiro, S. M., Bilderback, A. L., Oliveira, M.-V. C., Leitão, F. S., Queiroga, F., Lorenzi-Filho, G., & Krishnan, J. A. (2010) · European Respiratory Journal · doi:10.1183/09031936.00192008 · Cited by 197 · cited 1×
“Treatment of COPD patients with OSAS is based on the treatment of constituent diseases (for COPD bronchodilators, inhaled steroids when indicated, rehabilitation, nutrition, domiciliary oxygen when indicated, and for OSA weight loss and application of continuous positive airway pressure [CPAP]).(107,108) The goal of t…”
Chronic Obstructive Pulmonary Disease: Effects beyond the Lungs
Barnes, P. J. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000220 · Cited by 197
Concealed Renal Insufficiency and Adverse Drug Reactions in Elderly Hospitalized Patients
Corsonello, A. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.7.790 · Cited by 193
Bower, P., Macdonald, W., Harkness, E., Gask, L., Kendrick, T., Valderas, J. M., Dickens, C., Blakeman, T., & Sibbald, B. (2011) · Family Practice · doi:10.1093/fampra/cmr018 · Cited by 191
Pooler, A., & Beech, R. (2014) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s53255 · Cited by 191 · cited 1×
“Anxiety is also more frequent among COPD patients, compared with the general population or patients with other chronic illnesses, with a prevalence reported to be as high as 19%.(92) Patients with anxiety tend to have their first hospitalization earlier in the natural course of COPD,(93) they are earlier and more inte…”
Increased Prevalence of Gastroesophageal Reflux Symptoms in Patients With COPD
Mokhlesi, B., Morris, A. L., Huang, C.-F., Curcio, A. J., Barrett, T. A., & Kamp, D. W. (2001) · Chest · doi:10.1378/chest.119.4.1043 · Cited by 185 · cited 1×
“Studies show a significant prevalence of GERD in up to 60% of COPD patients, which is correlated more with quality of life scores on the COPD Assessment Test than with airway obstruction(113) and risk for exacerbation.(19,114) These findings raise more questions as to whether COPD patients are dealing with an independ…”
Impact of gastro-oesophageal reflux disease symptoms on COPD exacerbation
Terada, K., Muro, S., Sato, S., Ohara, T., Haruna, A., Marumo, S., Kinose, D., Ogawa, E., Hoshino, Y., Niimi, A., et al. (2008) · Thorax · doi:10.1136/thx.2007.092858 · Cited by 185 · cited 1×
“Studies show a significant prevalence of GERD in up to 60% of COPD patients, 110–112 which is correlated more with quality of life scores on the COPD Assessment Test than with airway obstruction 113 and risk for exacerbation.”
Cardiovascular Safety of Tiotropium in Patients With COPD
Celli, B., Decramer, M., Leimer, I., Vogel, U., Kesten, S., & Tashkin, D. P. (2010) · Chest · doi:10.1378/chest.09-0011 · Cited by 184 · cited 1×
“least 3 years has not been associated with worsening major clinical features of osteoporosis.(155) On the other hand, oral corticosteroids can potentially worsen coexistent heart failure, and are associated with an increased risk of arrhythmias.”
The natural history of chronic obstructive pulmonary disease
Mannino, D. M., & Hudson, N. L. (2009) · Explore Bristol Research · doi:10.1183/09031936.06.00024605 · Cited by 176
Corticosteroids and the Risk of Atrial Fibrillation
van der Hooft, C. S., Heeringa, J., Brusselle, G. G., Hofman, A., Witteman, J. C. M., Kingma, J. H., Sturkenboom, M. C. J. M., & Stricker, B. H. C. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.9.1016 · Cited by 176
Role of Gastroesophageal Reflux Symptoms in Exacerbations of COPD
Rascon-Aguilar, I. E., Pamer, M., Wludyka, P., Cury, J., Coultas, D., Lambiase, L. R., Nahman, N. S., & Vega, K. J. (2006) · Chest · doi:10.1378/chest.130.4.1096 · Cited by 173 · cited 2×
“COPD patients have approximately twice the incidence of acute renal failure, and three times the prevalence of diagnosed chronic renal failure than agematched and gender-matched controls.(115) Renal insufficiency may be present in around 22% of COPD patients.”
Laurin, C., Lavoie, K. L., Bacon, S. L., Dupuis, G., Lacoste, G., Cartier, A., & Labrecque, M. (2007) · Chest · doi:10.1378/chest.07-0134 · Cited by 168 · cited 1×
“Anxiety is one of the known comorbidities with the highest risk of death, especially among female patients,(95) that needs adequate attention as it is a potentially treatable condition.(96) The prevalence of depression in COPD patients receiving long-term oxygen therapy reaches as high as 60%.”
A user's guide to selecting a comorbidity index for clinical research
HALL, S. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.11.013 · Cited by 167 · cited 2×
“These include the Charlson Comorbidity Index, the Cumulative Illness Rating Scale, the Index of Coexisting Disease, and the Kaplan Index.(10,151) The COTE index (a COPD-specific comorbidity test) identified 12 comorbidities that predicted death in COPD patients and is suggested as a complementary tool to the BODE (BMI…”
Pasquale, M., Sun, Song, Hartnett, & Stemkowski (2012) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s36997 · Cited by 167
Relation of Chronic Obstructive Pulmonary Disease to Atrial and Ventricular Arrhythmias
Konečný, T., Park, J. Y., Somers, K. R., Konecny, D., Orban, M., Souček, F., Parker, K. O., Scanlon, P. D., Asirvatham, S. J., Brady, P. A., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.04.030 · Cited by 166 · cited 1×
“and COPD are associated with a higher incidence of atrial fibrillation after adjustment for confounders.(44) The preva-”
Fletcher, M. J., Upton, J., Taylor-Fishwick, J. C., Buist, S. A., Jenkins, C. R., Hutton, J., Barnes, N. C., van der Molen, T., Walsh, J. W., Jones, P., et al. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-612 · Cited by 161
Comorbidities in patients with COPD and pulmonary rehabilitation: do they matter?
Franssen, F. M. E., & Rochester, C. L. (2014) · European Respiratory Review · doi:10.1183/09059180.00007613 · Cited by 158 · cited 1×
“Left ventricular dysfunction is present in around 20% of COPD patients, but frequently goes unnoticed.(38)”
Sin, D. D., & Man, S. F. P. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(03)00263-0 · Cited by 157 · cited 1×
“Atrial fibrillation Atrial fibrillation and COPD are two common morbidities and often coexist.(42) The presence and severity of COPD are”
Sex-related differences in COPD in five Latin American cities: the PLATINO study
Varela, M. V. L., de, M. M., Halbert, R. J., Muiño, A., Pérez‐Padilla, R., Tálamo, C., Jardim, J. R., Valdivia, G. G., Pertuzé, J., Moreno, D., et al. (2010) · European Respiratory Journal · doi:10.1183/09031936.00165409 · Cited by 156
Li, J., Agarwal, S. K., Alonso, Á., Blecker, S., Chamberlain, A. M., London, S. J., Loehr, L. R., McNeill, A. M., Poole, C., Soliman, E. Z., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.004050 · Cited by 156 · cited 1×
“lence of COPD in patients with atrial fibrillation reaches 18%.(45) Hospitalization mortality in severe COPD patients”
Schönhofer, B., Wenzel, M. T., Geibel, M., & Köhler, D. (1998) · Critical Care Medicine · doi:10.1097/00003246-199811000-00022 · Cited by 152 · cited 3×
“Osteoporosis is associated with higher dyspnea scores and reduced six-minute walking distance.(30) Patients with COPD and osteoporosis”
InfluentialHeart Failure and Chronic Obstructive Pulmonary Disease
Hawkins, N. M., Petrie, M. C., MacDonald, M. R., Jhund, P. S., Fabbri, L. M., Wikstrand, J., & McMurray, J. J. V. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.02.020 · Cited by 151 · cited 1×
“Tiotropium, on the other hand, has been associated with a reduction in the risk of all-cause mortality, cardiovascular mortality, and cardiovascular events.(154) Even if few long-term studies have measured changes in bone mineral density, inhaled steroid use for at”
Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony
Mirrakhimov, A. E. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-132 · Cited by 148 · cited 2×
“Without overlooking other pathways, like hypoxia and oxidative stress, the mainstream approach is that a variety of inflammatory mediators, including interferon-γ, interleukin-1, C-reactive protein, tumor necrosis factor-α, interleukin-6, interleukin-8, surfactant protein D, fibrinogen, and amyloid protein, from the p…”
Mortality in COPD: The Role of Comorbidities
Sin, D. D. (2012) · Chronic Obstructive Pulmonary Disease · doi:10.1007/978-1-60761-673-3_1 · Cited by 146
Chronic Obstructive Pulmonary Disease: The Disease and Its Burden to Society
Halpin, D. M. G., & Miravitlles, M. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200603-093ss · Cited by 139 · cited 1×
“Elevated costs in comorbid COPD patients are not only associated with hospitalizations: COPD patients use approximately 50% more cardiovascular agents than age-matched and sexmatched controls, and almost twice as many antibiotics, analgesics, and psychotherapeutic medications.(138) COPD patients with multiple comorbid…”
Tkáčová, R. (2010) · Mediators of Inflammation · doi:10.1155/2010/585989 · Cited by 138 · cited 1×
“Some researchers go as far as to propose that COPD is just a manifestation of a systemic inflammatory syndrome.(71) COPD medications may also contribute to the development or worsening of certain comorbidities.”
Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease
MacNee, W. (2012) · Annals of Medicine · doi:10.3109/07853890.2012.732703 · Cited by 137
Gottlieb, S. S., McCarter, R., & Vogel, R. A. (1999) · Survey of Anesthesiology · doi:10.1097/00132586-199908000-00014 · Cited by 137
The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial
(2005) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000162922.49505.7a · Cited by 134
Loss of Bone Density with Inhaled Triamcinolone in Lung Health Study II
Scanlon, P. D., Connett, J. E., Wise, R. A., Tashkin, D. P., Madhok, T. C., Skeans, M. A., Carpenter, P. C., Bailey, W. C., Buist, A. S., Eichenhorn, M. S., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200310-1349oc · Cited by 133
Brekke, P., Omland, T., Smith, P., & Søyseth, V. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.04.010 · Cited by 131 · cited 1×
“The key mediator of this sustained inflammation in COPD is probably elevated C-reactive protein levels, which not only maintain bronchial constriction but also increase the risk for coronary disease.(24,41)”
Patel, J. G., Dalal, A. A., & Nagar, S. P. (2014) · International Journal of COPD · doi:10.2147/copd.s57157 · Cited by 130 · cited 1×
“5 billion in 2010, the largest part consisting of hospital expenses,(134) whereas indirect costs accounted for 27%–61% of total costs, with the higher estimates produced by studies of working age populations.(135,136) Average lifetime earnings losses for COPD patients retiring early have been estimated to be $316,000…”
Depression and Health-Related Quality of Life in Chronic Obstructive Pulmonary Disease
Omachi, T. A., Katz, P. P., Yelin, E. H., Gregorich, S. E., Iribarren, C., Blanc, P. D., & Eisner, M. D. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.01.036 · Cited by 128 · cited 1×
“97 Depression reduces physical activity, quality of life scores, 98,99 and adherence to medical treatment, 100 and is associated with higher rates of COPD exacerbations 101,102 and increased mortality.”
Mascarenhas, J., Lourenço, P., Lopes, R., Azevedo, A., & Bettencourt, P. (2008) · American Heart Journal · doi:10.1016/j.ahj.2007.10.040 · Cited by 128 · cited 2×
“Coexistence of COPD and congestive heart failure worsens right ventricular dysfunction, when compared with non-COPD patients.(37) Left ventricular dysfunction is present in around 20% of COPD patients, but frequently goes unnoticed.”
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
&NA; (2008) · Survey of Anesthesiology · doi:10.1097/01.sa.0000296390.40047.dc · Cited by 127
Asthma, chronic obstructive pulmonary disease, and type 2 diabetes in the Women's Health Study
Song, Y., Klevak, A., Manson, J. E., Buring, J. E., & Liu, S. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.09.010 · Cited by 123 · cited 1×
“COPD patients have a relatively increased risk of developing diabetes,(66,67) but also diabetes often presents before diagnosis of COPD, and diabetic patients have an increased risk of developing COPD.(68) This side-by-side development of both diseases is a result of common risk factors, like smoking, and also the syn…”
Chromosome 4q31 locus in COPD is also associated with lung cancer
Young, R. P., Whittington, C. F., Hopkins, R. J., Hay, B. A., Epton, M., Black, P., & Gamble, G. D. (2010) · European Respiratory Journal · doi:10.1183/09031936.00033310 · Cited by 116 · cited 1×
“Lung cancer and COPD may share certain risk factors, like age, smoking, or genetic predisposition, but bronchial and systemic inflammation due to COPD may also contribute to carcinogenesis, swifting cancer to dependent comorbidity.(121,122) The same is evident in several”
Undertreatment of COPD: a retrospective analysis of US managed care and Medicare patients
Dutro, M. P., Make, Paulose-Ram, Marton, J. P., Mapel, D. W., Make, B. J., & Paulose‐Ram, R. (2012) · International Journal of COPD · doi:10.2147/copd.s27032 · Cited by 115 · cited 1×
“Despite the abundance of data on smoking, only a small percentage of smokers in the USA have received any kind of smoking cessation intervention.(172,173) Similarly, the percentage of the population that currently receives influenza vaccination is also low.”
Parappil, A., Depczynski, B., COLLETT, P., & Marks, G. B. (2010) · Respirology · doi:10.1111/j.1440-1843.2010.01781.x · Cited by 115 · cited 1×
“Osteoporosis Osteoporosis is another chronic illness that frequently coexists with COPD, even in male patients.(75,76) The prevalence of osteoporosis among COPD patients ranges up to 69% in some reports, reflecting not only common risk factors, like age and cigarette smoking, but also the harmful effects of COPD due t…”
Prevalence and impact of depression in chronic obstructive pulmonary disease patients
Norwood, R. (2006) · Current Opinion in Pulmonary Medicine · doi:10.1097/01.mcp.0000208450.50231.c6 · Cited by 114
The Effects of Hypoxia on Markers of Coagulation and Systemic Inflammation in Patients With COPD
Sabit, R., Thomas, P. S., Shale, D. J., Collins, P. W., & Linnane, S. J. (2010) · CHEST Journal · doi:10.1378/chest.09-2764 · Cited by 113 · cited 1×
“ing, but also systemic inflammation due to COPD induces pulmonary(55) and systemic endothelial dysfunction(56) and coagulopathy.(24,57,58)”
(1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.supplement_1.99titlepage · Cited by 112
Comorbidities of chronic obstructive pulmonary disease
Corsonello, A., Incalzi, R. A., Pistelli, R., Pedone, C., Bustacchini, S., & Lattanzio, F. (2011) · Current Opinion in Pulmonary Medicine · doi:10.1097/01.mcp.0000410744.75216.d0 · Cited by 112 · cited 3×
“about the disease, precise prevalence numbers differ in the published epidemiological studies (see Table 1).(3) There is”
Lung cancer gene associated with COPD: triple whammy or possible confounding effect?
Young, R. P., Hopkins, R. J., Hay, B. A., Epton, M., Black, P., & Gamble, G. D. (2008) · European Respiratory Journal · doi:10.1183/09031936.00093908 · Cited by 111 · cited 1×
“cardiovascular diseases, which also share common risk factors and seem to have a bidirectional inflammatory link with COPD that impairs outcomes for both diseases.(123,124) Type 2 diabetes has been considered as a coincidental comorbidity, but evidence is accumulating in favor of considering diabetes and metabolic syn…”
Lung Function and Ischemic Stroke Incidence
Hozawa, A., Billings, J. L., Shahar, E., Ohira, T., Rosamond, W. D., & Folsom, A. R. (2006) · CHEST Journal · doi:10.1378/chest.130.6.1642 · Cited by 110 · cited 1×
“Almost 8% of all COPD patients have a history of stroke.(62) About 4% of”
Analysis of comorbid factors that increase the COPD assessment test scores
Miyazaki, M., Nakamura, H., Chubachi, S., Sasaki, M., Haraguchi, M., Yoshida, S., Tsuduki, K., Shirahata, T., Takahashi, S., Minematsu, N., et al. (2014) · Respiratory Research · doi:10.1186/1465-9921-15-13 · Cited by 108
Kaczmarek, P., Sładek, K., Stępień, E. Ł., Skucha, W., Rzeszutko, M., Górkiewicz-Kot, I., Tracz, W., & Undas, A. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-02-0118 · Cited by 107 · cited 1×
“smoking, and the systemic inflammation and coagulopathy caused by COPD.(59,60) There is a linear correlation between stroke risk and airflow obstruction.”
Yohannes, A. M., Baldwin, R. C., & Connolly, M. J. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.851 · Cited by 106 · cited 1×
“thirds of patients with coexistent COPD and depression do not receive any antidepressant treatment.(88,105)”
Systemic Inflammation in Older Adults With Asthma-COPD Overlap Syndrome
Fu, J., McDonald, V. M., Gibson, P. G., & Simpson, J. L. (2014) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2014.6.4.316 · Cited by 105 · cited 1×
“In some studies, the overlap diagnosis of asthma and COPD exceeds half of the patients examined.(13,14)”
Kiri, V. A., Soriano, J. B., Visick, G., & Fabbri, L. M. (2009) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2009.00048 · Cited by 104 · cited 1×
“It is also a factor that contributes to poorer outcomes in lung cancer patients.(20,21) The prevalence of COPD among patients with lung cancer varies from 40% to 70%.”
Watanabe, R., Tanaka, T., Aita, K., Hagiya, M., Homma, T., Yokosuka, K., Yamakawa, H., Yarita, T., 宣之, 田., Hirano, J., et al. (2014) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-014-0605-7 · Cited by 104 · cited 1×
“Osteoporosis Osteoporosis is another chronic illness that frequently coexists with COPD, even in male patients.(75,76) The prevalence of osteoporosis among COPD patients ranges up to 69% in some reports, reflecting not only common risk factors, like age and cigarette smoking, but also the harmful effects of COPD due t…”
Jones, S. F. (2011) · Yearbook of Medicine · doi:10.1016/s0084-3873(11)00250-1 · Cited by 103
High Prevalence of Proximal and Distal Gastroesophageal Reflux Disease in Advanced COPD
Kempainen, R. R., Savik, K., Whelan, T. P. M., Dunitz, J., Herrington, C. S., & Billings, J. L. (2007) · CHEST Journal · doi:10.1378/chest.06-2264 · Cited by 103
Anecchino, C., Rossi, E., Fanizza, C., Rosa, M. D., Tognoni, G., & Romero, M. (2007) · PubMed Central · Cited by 102
Exercise and the Treatment of Diabetes and Obesity
O’Gorman, D. J., & Krook, A. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.07.006 · Cited by 101
Depression and its relationship with poor exercise capacity, BODE index and muscle wasting in COPD
Al-shair, K., Dockry, R., Mallia-Milanes, B., Kolsum, U., Singh, D., & Vestbo, J. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2008.11.021 · Cited by 101 · cited 1×
“97 Depression reduces physical activity, quality of life scores, 98,99 and adherence to medical treatment, 100 and is associated with higher rates of COPD exacerbations 101,102 and increased mortality.”
The Association Between Depressive Symptoms and Acute Exacerbations of COPD
Jennings, J. H., DiGiovine, B., Obeid, D., & Frank, C. (2009) · Lung · doi:10.1007/s00408-009-9135-9 · Cited by 100 · cited 1×
“Depression reduces physical activity, quality of life scores,(98,99) and adherence to medical treatment,(100) and is associated with higher rates of COPD exacerbations(101,102) and increased mortality.(103) Almost 25% of all COPD patients suffer from depression that eludes diagnosis,(104) and an estimated two”
Musculoskeletal Disorders in Chronic Obstructive Pulmonary Disease
Cielen, N., Maes, K., & Gayan‐Ramirez, G. (2014) · BioMed Research International · doi:10.1155/2014/965764 · Cited by 99 · cited 1×
“84 87 Early onset of muscle weakness may reflect a more aggressive COPD phenotype.”
Frei, A. L., Muggensturm, P. M., Putcha, N., Siebeling, L., Zoller, M., Boyd, C. M., ter Riet, G., & Puhan, M. A. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.03.005 · Cited by 97 · cited 1×
“LABA have been associated with increased mortality and hospitalization in patients with heart failure and an increased risk of incident heart failure.(153) Tiotropium, on the other hand, has been associated with a reduction in the risk of all-cause mortality, cardiovascular mortality, and cardiovascular events.”
Respiratory Medications and the Risk of Cardiac Arrhythmias
Huerta, C., Lanes, S., & Rodríguez, L. A. G. (2005) · Epidemiology · doi:10.1097/01.ede.0000158743.90664.a7 · Cited by 94 · cited 1×
“logical actions in the same molecule, which are now called “bifunctional drugs”.(159)”
Economic burden of chronic obstructive pulmonary disease
TEO, W. ‐. K., Tan, W. S., CHONG, W., Abisheganaden, J. A., Lew, Y.-J., LIM, T., & Heng, B. H. (2011) · Respirology · doi:10.1111/j.1440-1843.2011.02073.x · Cited by 90
the NETT Research Group, Giardino, N. D., Curtis, J. L., Andrei, A.-C., Fan, V. S., Benditt, J. O., Lyubkin, M., Naunheim, K., Criner, G., Make, B., et al. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-29 · Cited by 88
Koskela, J. T., Kilpeläinen, M., Kupiainen, H., Mazur, W., Sintonen, H., Boezen, M., Lindqvist, A. E., Postma, D. S., & Laitinen, T. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-102 · Cited by 86 · cited 1×
“Comorbidities are most often responsible for impairing quality of life for early-stage patients, 6 for increasing mortality in end-stage patients, for increasing the burden of COPD management on health care costs, and creating therapeutic dilemmas for health care providers.”
Abrams, T. E., Vaughan‐Sarrazin, M., & Weg, M. W. V. (2011) · Psychosomatics · doi:10.1016/j.psym.2011.03.005 · Cited by 85 · cited 1×
“94 Anxiety is one of the known comorbidities with the highest risk of death, especially among female patients, 95 that needs adequate attention as it is a potentially treatable condition.”
Exercise training and peripheral vascular disease
Tan, K. H., de Cossart, L., & Edwards, P. R. (2000) · Journal of British Surgery · doi:10.1046/j.1365-2168.2000.01445.x · Cited by 76
Abdominal fat mass contributes to the systemic inflammation in chronic obstructive pulmonary disease
Rutten, E. P. A., Breyer, M., Spruit, M. A., Hofstra, T., van Melick, P. P. M. J., Schols, A. M. W. J., & Wouters, E. F. �. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2010.04.007 · Cited by 74 · cited 1×
“prevalence of skeletal muscle weakness has been reported to be as high as 32% among COPD patients.(83) Skeletal muscle”
Bifunctional drugs for the treatment of asthma and chronic obstructive pulmonary disease
Page, C. P., & Cazzola, M. (2014) · European Respiratory Journal · doi:10.1183/09031936.00003814 · Cited by 73
Petersen, H. V., Sood, A., Meek, P., Shen, X., Cheng, Y., Belinsky, S. A., Owen, C. A., Washko, G. R., Pinto-Plata, V., Kelly, E. M., et al. (2013) · CHEST Journal · doi:10.1378/chest.13-0799 · Cited by 73
Rodríguez, L. A. G., Wallander, M.-A. A., Martín‐Merino, E., & Johansson, S. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.04.018 · Cited by 72 · cited 1×
“Simultaneously, COPD is an independent risk factor for death in patients with congestive heart failure.(36) Coexistence of COPD and congestive heart failure worsens right ventricular dysfunction, when compared with non-COPD patients.”
Vaidyula, V. R., Criner, G. J., Grabianowski, C. L., & Rao, A. K. (2009) · Thrombosis Research · doi:10.1016/j.thromres.2008.12.030 · Cited by 72 · cited 1×
“There is a linear correlation between stroke risk and airflow obstruction.(61) Almost 8% of all COPD patients have a history of stroke.”
Added value of co-morbidity in predicting health-related quality of life in COPD patients
van Manen, J. G., Bindels, P., Dekker, F. W., IJzermans, C. J., Bottema, B. J. A. M., van der Zee, J. S., & Schade, E. (2001) · Respiratory Medicine · doi:10.1053/rmed.2001.1077 · Cited by 68 · cited 1×
“149 Attempts have been made to measure the relevant effect of multiple concomitant COPD comorbidities on outcomes, especially mortality, using several indexes or scales, which are not always designed exclusively for COPD patients.”
Eriksson, B., Lindberg, A., Müllerová, H., Rönmark, E., & Lundbäck, B. (2012) · Respiratory Medicine · doi:10.1016/j.rmed.2012.09.011 · Cited by 68 · cited 1×
“ing, and common pathophysiological mechanisms, which frequently coexist in the same patient.(32) The prevalence of congestive heart failure among COPD patients varies between stable disease and exacerbations.”
Spitzer, C., Gläser, S., Grabe, H. J., Ewert, R., Barnow, S., Felix, S. B., Freyberger, H. J., Völzke, H., Koch, B., & Schäper, C. (2011) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2011.03.005 · Cited by 65 · cited 1×
“92 Patients with anxiety tend to have their first hospitalization earlier in the natural course of COPD, 93 they are earlier and more intensely irritated by their shortness of breath, and have higher rates of mortality and readmission after an exacerbation.”
Determinants of elevated healthcare utilization in patients with COPD
Simon‐Tuval, T., Scharf, S. M., Maimon, N., Bernhard-Scharf, B. J., Reuveni, H., & Tarasiuk, A. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-7 · Cited by 62 · cited 1×
“Comorbidities, after age and chronic symptoms, are the factors most predictive of future health care costs.(140) COPD patients with comorbidities have increased risk(66) and significantly higher mean costs for hospital admissions.”
Exercise and the Treatment of Diabetes and Obesity
O’Gorman, D. J., & Krook, A. (2011) · Medical Clinics of North America · doi:10.1016/j.mcna.2011.06.007 · Cited by 61
Örnek, T., Tor, M. M., Altın, R., Atalay, F., Geredeli, E., Soylu, Ö., & Erboy, F. (2012) · International Journal of Medical Sciences · doi:10.7150/ijms.4039 · Cited by 59 · cited 1×
“5 billion in 2010, the largest part consisting of hospital expenses,(134) whereas indirect costs accounted for 27%–61% of total costs, with the higher estimates produced by studies of working age populations.(135,136) Average lifetime earnings losses for COPD patients retiring early have been estimated to be $316,000…”
Huang, B., Yang, Y., Zhu, J., Liang, Y., Zhang, H., Li, T. X., Shao, X., & Wang, J. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.04.009 · Cited by 56 · cited 1×
“43 Reduced FEV 1 and COPD are associated with a higher incidence of atrial fibrillation after adjustment for confounders.”
Regvat, J., Žmitek, A., Vegnuti, M., Košnik, M., & Šuškovič, S. (2011) · Journal of International Medical Research · doi:10.1177/147323001103900338 · Cited by 55 · cited 1×
“Patients with anxiety tend to have their first hospitalization earlier in the natural course of COPD,(93) they are earlier and more intensely irritated by their shortness of breath, and have higher rates of mortality and readmission after an exacerbation.(94) Anxiety is one of the known comorbidities with the highest…”
Sleep Abnormalities and Treatment in Emphysema
Krachman, S. L., Minai, O. A., & Scharf, S. M. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200708-134et · Cited by 53 · cited 1×
“Treatment of COPD patients with OSAS is based on the treatment of constituent diseases (for COPD bronchodilators, inhaled steroids when indicated, rehabilitation, nutrition, domiciliary oxygen when indicated, and for OSA weight loss and application of continuous positive airway pressure [CPAP]).(107,108) The goal of t…”
Fumagalli, G., Fabiani, F., Forte, S., Napolitano, M., Marinelli, P., Palange, P., Pentassuglia, A., Carlone, S., & Sanguinetti, C. M. (2013) · Multidisciplinary Respiratory Medicine · doi:10.1186/2049-6958-8-28 · Cited by 51 · cited 1×
“30,147 The presence of three or more comorbidities is a better predictor of impaired health status than any other demographic or clinical variable.”
The prevalence of undiagnosed renal failure in a cohort of COPD patients in western Norway
Gjerde, B., Bakke, P. S., Ueland, T., Hardie, J. A., & Eagan, T. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.10.004 · Cited by 48 · cited 2×
“as a systematic inflammatory disease, our focus is shifting from the lungs.(119) In te rn at io na l J ou rn al o f C hr on ic O bs tr uc tiv e P ul m on ar y D is ea se d ow nl oa de d fr om h ttp s: //w w w .”
Update on pulmonary hypertension complicating chronic obstructive pulmonary disease
Safdar, Z., & Jyothula, S. (2009) · International Journal of COPD · doi:10.2147/copd.s5102 · Cited by 47
Rising Costs of COPD and the Potential for Maintenance Therapy to Slow the Trend.
Blanchette, C. M., Gross, N. J., & Altman, P. (2014) · PubMed · Cited by 44
ACE in COPD: a therapeutic target?
Forth, R., & Montgomery, H. (2003) · Thorax · doi:10.1136/thorax.58.7.556 · Cited by 42
Matera, M. G., Martuscelli, E., & Cazzola, M. (2009) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2009.10.001 · Cited by 42
Darnell, K., Dwivedi, A. K., Weng, Z., & Panos, R. J. (2013) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-11-13 · Cited by 40 · cited 1×
“142 Exacerbations are the leading but not the only cause of hospital admissions, and account for between 40% and 75% of the total health care cost of COPD, 143,144 despite treatment with maintenance medications.”
Neurological and endocrinological disorders: orphans in chronic obstructive pulmonary disease
Doehner, W., Hæusler, K. G., Endres, M., Anker, S. D., MacNee, W., & Lainščak, M. (2011) · Respiratory Medicine · doi:10.1016/s0954-6111(11)70005-1 · Cited by 34 · cited 1×
“smoking, and the systemic inflammation and coagulopathy caused by COPD.(59,60) There is a linear correlation between stroke risk and airflow obstruction.”
Osteoporosis Risk in Patients With Chronic Obstructive Pulmonary Disease: The EOLO Study
Maggi, S., Siviero, P., Gonnelli, S., Schiraldi, C., Malavolta, N., Nuti, R., & Crepaldi, G. (2009) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2009.05.003 · Cited by 33
Do We Need Different Treatments for Very Elderly COPD Patients?
Valente, S., Pasciuto, G., Bernabei, R., & Corbo, G. M. (2010) · Respiration · doi:10.1159/000320221 · Cited by 33
Qian, J., Simoni‐Wastila, L., LANGENBERG, P. W., Rattinger, G. B., Zuckerman, I. H., Lehmann, S. W., & Terrin, M. C. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12220 · Cited by 29
Patients With COPD Cardiovascular Safety of Tiotropium in
Tashkin, D. P., Celli, B. R., Decramer, M., Leimer, I., & Vogel, U. (2010) · Cited by 28
Depression and Health-Related Quality of Life in Chronic Obstructive Pulmonary Disease.
Omachi, T., Katz, P. P., Yelin, E., Gregorich, S., Iribarren, C., Blanc, P. D., & Eisner, M. (2009) · doi:10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a1073 · Cited by 27
Chronic Renal Failure: A Neglected Comorbidity of COPD
MAURER, J. R. (2011) · Yearbook of Pulmonary Disease · doi:10.1016/j.ypdi.2010.12.010 · Cited by 27
Hayashi, T., Fukamizu, S., Hojo, R., Komiyama, K., Tanabe, Y., Tejima, T., Nishizaki, M., Hiraoka, M., Ako, J., Momomura, S., et al. (2013) · EP Europace · doi:10.1093/europace/eut158 · Cited by 26 · cited 1×
“This remodeling occurs in COPD due to endothelial dysfunction, clotting abnormalities, hypoxic vasoconstriction, destruction of the pulmonary capillary bed, inflammatory infiltration of the vascular wall, and shear stress due to blood flow redistribution.(48) Reports estimate that the prevalence of pulmonary artery hy…”
Rutten, F. H., Vonken, E. J., Cramer, M. J., Moons, K. G. M., Velthuis, B. K., Prakken, N. H. J., Lammers, J. J., Grobbee, D. E., Mali, W. P. T. M., & Hoes, A. W. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.04.021 · Cited by 22 · cited 1×
“Vigilance in recognizing and diagnosing coronary disease signs and symptoms is needed in assessing COPD patients.(39) In some studies of the medical records of COPD patients, undiagnosed cases of coronary heart disease reach 70%.”
Lee, D. S. H., Markwardt, S., McAvay, G., Gross, C. P., Goeres, L. M., Han, L., Peduzzi, P. N., Lin, H., Dodson, J. A., & Tinetti, M. E. (2014) · Medical Care · doi:10.1097/mlr.0000000000000035 · Cited by 17 · cited 1×
“161,162 However, even older nonselective β -blockers are well tolerated in most COPD patients.”
Cardiac arrhythmias in patients with serious pulmonary diseases.
Gulsvik, A., Hansteen, & SIVERTSSEN, E. (1978) · PubMed · Cited by 16
Chen, C., Hsu, T.-W., Mao, S. J. T., Chang, S.-C., Yang, P., Lee, Y.-C., & Yang, K. (2013) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2012.719051 · Cited by 16 · cited 2×
“Renal insufficiency may be present in around 22% of COPD patients.(117) Chronic renal failure often goes undiagnosed, and is a particular concern in elderly COPD patients and in COPD patients with cachexia.”
Doos, L., Uttley, J., Onyia, I., Iqbal, Z., Jones, P. W., & Kadam, U. T. (2013) · Journal of Public Health · doi:10.1093/pubmed/fdt070 · Cited by 14 · cited 2×
“COPD patients with multiple comorbidities make use of a disproportionately large percentage of the total overall health care expenditure on COPD.(142,145) The median cost of COPD patients with multiple comorbidities has been found to”
London, S. J., Soliman, E. Z., Alonso, Á., Chamberlain, A. M., Poole, C., Li, J., McNeill, A. M., Loehr, L. R., HEISS, G. M., Agarwal, S. K., et al. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/9rdt-fr33 · Cited by 10
Is the Use of β-Blockers in COPD Still an Unresolved Dilemma?
Foresi, A., Cavigioli, G., Signorelli, G., Pozzoni, M. B., & Olivieri, D. (2010) · Respiration · doi:10.1159/000318583 · Cited by 8 · cited 1×
“161,162 However, even older nonselective β -blockers are well tolerated in most COPD patients.”
Metadata
- Authors
- Tzanakis, N., Hillas, G., Perlikos, F., & Tsiligianni, I.
- Venue
- International Journal of Chronic Obstructive Pulmonary Disease
- Publisher
- Informa UK Limited
- Published
- 2015-01
- Volume
- 10
- Pages
- 95
- ISSN
- 1176-9106 (ISSN-L)
- 1178-2005
- OpenAlex
- W2091099582
- Cited by
- 251
- References
- 185
- FWCI
- 17.60
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.